ftInvstr
SASTASUNDR · Healthcare ₹301.5 +3.82% Mkt Cap ₹872 Cr
← Search another stock

SASTASUNDR

Healthcare Pharmaceutical Retailers
★ Watchlist ⧉ Add to bucket
₹301.5
+3.82% today · 30d -1.47%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SASTASUNDR. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹447 Cr
+49.73% YoY
NET PROFIT
₹2 Cr
-92.53% YoY
OPM
0.97%
-8.74pp YoY
EPS
₹0.8
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-10.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SASTASUNDR—-1.0
MEDPLUS37.6420.93
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation — —
Growth STEADY 58
Profitability LOW 18
Technicals NEUTRAL 55
Risk LOW 80
Key Stats
52W HIGH
₹363.0
OFF HIGH
-16.94%
MKT CAP
₹872 Cr
◉ Active Signals
MACDNeutral0.4146
RSI(14)Neutral50.3
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SASTASUNDR and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.